PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.437
https://www.valueinhealthjournal.com/article/S1098-3015(11)01999-1/fulltext
Section Title :
Muscular-Skeletal Disorders
Section Order :
410
First Page :
A311
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01999-1&doi=10.1016/j.jval.2011.08.437